Asia Pacific Pet Gut Health Market

Overview

The Asia Pacific pet gut health market was valued at USD 1.32 billion in 2025 and is projected to reach USD 2.86 billion by 2034, growing at a CAGR of 8.9% during the forecast period (2026-2034). The market growth is driven by rising pet ownership, increasing awareness of pet digestive health, growing demand for functional pet nutrition products, expansion of premium pet care products. The market is shifting from single-strain, mass-market probiotic powders toward strain-specific, clinically referenced synbiotic and postbiotic formats that offer greater shelf stability across the region's varied climates and cold-chain infrastructure. Government initiatives such as China's Ministry of Agriculture and Rural Affairs (MARA) issuing import registration certificates to 88 overseas enterprises for 187 feed and feed-additive products in July 2025, alongside its ongoing public consultation on revising the Catalogue of Feed Materials, are widening the pool of certified probiotic, prebiotic, and enzyme ingredient suppliers permitted to enter the Chinese market and are gradually formalising quality and safety oversight of gut-health pet products across the region. By country, China held the largest share of the Asia Pacific pet gut health market in 2025, supported by its large and fast-growing companion-animal population and expanding cross-border e-commerce access for certified imported ingredients, while India is projected to be the fastest-growing country market during the forecast period, driven by rapid growth in pet ownership and entry of international pet-care groups into the domestic market.

Market Size & Share

Market Dynamics

KEY MARKET TREND

Postbiotics and Precision Microbiome Formats Emerging as a Transformational Trend

• Pet food and supplement developers across the region are increasingly moving beyond live-culture probiotics toward heat-stable postbiotic and enzyme-probiotic blends that better withstand the region's warmer climates and longer, less consistent cold-chain distances outside Japan and South Korea.
• Industry technical sessions at Petfood Forum 2026, including presentations on enzyme-probiotic blends and oral probiotic solutions for dogs, reflect growing formulation innovation aimed specifically at improving ingredient stability and efficacy for Asian supply chains.
• Regional fermentation and biotechnology specialists are extending strain libraries developed for human nutrition into companion-animal gut-health platforms, supporting faster new-product introduction across powder, chew, and functional-treat formats.
• China's Ministry of Agriculture and Rural Affairs (MARA) issued Notice No. 923 on 15 July 2025, granting import registration certificates to 88 overseas enterprises for 187 feed and feed-additive products, widening the certified base of probiotic and prebiotic ingredient suppliers eligible to enter the Chinese market.

KEY MARKET DRIVER

Rising Companion-Animal Humanization and China's Growing "Cat Economy" are Key Drivers of Market Growth

• Pet owners across urban Asia Pacific increasingly regard companion animals as family members, driving a preference for preventive, wellness-oriented nutrition rather than reactive treatment, with digestive and immune health cited as leading purchase motivators for supplements and functional food.
• Japan's ageing pet population is increasing demand for senior-life-stage digestive support formats, while urban apartment living across the region is accelerating cat ownership relative to dogs, a segment with distinct gut-health nutrition needs.
• Expansion of veterinary clinic networks and pet specialty retail in China, India, and Southeast Asia is improving consumer access to professionally recommended gut-health products, supporting higher-value, clinically positioned purchases over generic alternatives.
• China’s 2026 local policies promote the development of the pet economy through pet-friendly spaces, improved veterinary services, e-commerce support, industry investment, and stronger quality and disease-control regulation for pet products.

KEY MARKET OPPORTUNITY

Regional Microbiome Innovation and Cross-Border Regulatory Access are Creating New Growth Avenues

• Southeast Asian biotechnology ventures are commercialising region-developed probiotic, prebiotic, and postbiotic strain technologies for companion-animal supplements, creating opportunities for locally sourced, regionally relevant gut-health ingredient platforms.
• Korean fermentation and food-ingredient groups with established human-nutrition microbiome platforms are positioned to extend proprietary strain and postbiotic technology into companion-animal formulations, supported by in-house biosciences research capability.
• Widening GACC and MARA import registration lists are lowering entry barriers for certified overseas probiotic and prebiotic ingredient suppliers seeking access to China, the region's largest single pet gut health market.
• Native Microbials and Zesty Paws, an H&H Group brand, announced a partnership to develop a canine gut-health product line built on novel microbial species isolated from the gut microbiomes of healthy dogs; separately, CJ Wellcare, a CJ CheilJedang affiliate working with microbiome specialist CJ Bioscience, unveiled its MACPlan gut-microbiome wellness brand in August 2026, illustrating how Korean fermentation science is diversifying into gut-health-adjacent product development that could extend to companion-animal applications.

Asia-Pacific Pet Gut Health Market Size, 2025-2034 (USD Billion)

Segmentation Analysis

Analysis by Product Type

Probiotics held the largest share of the Asia Pacific pet gut health market in 2025, supported by decades of consumer familiarity, broad veterinary recommendation, and the widest range of available strains, formats, and price points across the region. Established Lactobacillus and Bifidobacterium-based formulations remain the default recommendation for managing diarrhea, antibiotic-associated dysbiosis, and general digestive maintenance in dogs and cats, reinforced by their long-standing use in human nutrition, which builds consumer trust in Asian markets.

Postbiotics are projected to grow at the fastest CAGR during the forecast period, driven by their superior heat and shelf stability relative to live-culture probiotics, a significant advantage across Asia Pacific's varied climates and distribution infrastructure. Growing formulation interest from regional fermentation specialists and technical showcases at industry events highlighting enzyme-postbiotic blends are expected to accelerate adoption in premium supplement and functional-treat formats.

Product Type categories include

• Probiotics (Dominating Segment)
• Postbiotics (Highest CAGR Segment)
• Prebiotics
• Digestive Enzymes
• Others

Analysis by Form

Powder held the largest market share in 2025, reflecting strong regional consumer preference for easy-to-mix formats that allow flexible dosing across pet sizes and life stages, particularly in China and Southeast Asia where powders remain the default entry format for both mass-market and veterinary-recommended products. The format is also widely used for probiotic and digestive-health formulations, making it suitable for daily supplementation and preventive pet care.

Soft chews are projected to register the fastest CAGR through 2034, supported by premiumisation trends, improved palatability, and rising demand from urban pet owners for treat-like formats that combine gut-health functionality with convenience, mirroring broader growth in joint- and skin-health soft chews across the region's premium pet supplement segment. Growing product innovation, including multi-benefit formulations combining probiotics with vitamins, prebiotics, and digestive-support ingredients, is expected to further strengthen demand for soft chews.

Form categories include

• Powder (Dominating Segment)
• Soft Chews (Highest CAGR Segment)
• Capsules
• Liquid
• Functional Food

Analysis by Pet Type

Dogs accounted for the largest share of the market in 2025, reflecting the region's larger overall dog population, longer-established veterinary and retail infrastructure for canine health products, and greater consumer familiarity with dog-specific supplement dosing and formats. The growing availability of breed-, age-, and condition-specific gut-health products is also encouraging broader adoption among dog owners.

Cats are projected to be the fastest-growing pet type during the forecast period, led by China's expanding "cat economy," where cat food and related nutrition categories are growing faster than dog food amid rising urban apartment living and cat ownership among younger, single-person households across major Asia Pacific cities. E-commerce expansion and the convenience of online access to specialised feline wellness products are also supporting adoption among younger urban pet owners.

Pet Type categories include

• Dogs (Dominating Segment)
• Cats (Highest CAGR Segment)
• Others

Analysis by Distribution Channel

Veterinary Clinics held the largest market share in 2025, as pet owners across the region continue to rely on veterinary and in-store staff guidance when selecting gut-health products for conditions such as diarrhea and food sensitivity. The availability of personalised product recommendations and professional guidance also increases consumer confidence in purchasing specialised pet digestive-health products.

Online channels are projected to grow at the fastest CAGR during the forecast period, supported by expanding cross-border e-commerce access to certified imported ingredients and brands, particularly in China, and rising direct-to-consumer subscription models for supplement replenishment across urban Asia Pacific markets. The increasing use of mobile commerce and digital pet-care platforms is also improving access to specialised products in underserved markets across the region.

Distribution Channel categories include

• Veterinary Clinics (Dominating Segment)
• Online Channels (Highest CAGR Segment)
• Pet Specialty Stores
• Supermarkets 

By Region

China held the largest share of the Asia Pacific pet gut health market in 2025, driven by the country's large and rapidly growing companion-animal population and a pet consumer market estimated at RMB 320 billion (around USD 44 billion) in 2025. Regulatory formalisation under the General Administration of Customs (GACC) and the Ministry of Agriculture and Rural Affairs (MARA), including the July 2025 registration of 88 overseas enterprises for 187 feed and feed-additive products, is widening access to certified imported probiotic and prebiotic ingredients. China's fast-growing "cat economy" and expanding veterinary and pet specialty retail networks in tier-one and tier-two cities are supporting continued demand for both mass-market and premium gut-health supplements and functional food, while domestic pet nutrition companies are scaling functional treat and supplement portfolios alongside established global entrants.

India is projected to grow at the fastest CAGR during the forecast period, supported by rapidly rising pet ownership, a young and expanding middle-class consumer base, and the entry of international pet-care groups establishing local operations, including Unicharm Corporation's 2026 launch of its own pet-care brands through its Unicharm India subsidiary. India's pet population is significantly larger than that of more mature Asia Pacific markets such as Japan, providing substantial headroom for gut-health category education and product penetration as veterinary infrastructure and organised pet specialty retail continue to expand across the country's major urban centres.

Countries and Rest of Asia-Pacific

• China (Largest Country Market)
• Japan
• South Korea
• India (Fastest-Growing Country Market)
• Rest of APAC

Market Share

The market is fragmented, combining large global animal health, pet food, and ingredient manufacturers such as Mars, Incorporated, Novonesis, DSM-Firmenich AG, Alltech, Inc., Kemin Industries, Inc., Lallemand Inc., Vetoquinol S.A., Unicharm Corporation, Nutramax Laboratories Veterinary Sciences, Inc., Tonisity International Limited, Sirius Pet Biologics Pte. Ltd., Gambol Pet Group Co., Ltd., PetPal Pet Nutrition Technology Co., Ltd., and Inaba Petfood Co., Ltd., with a growing base of specialised regional supplement makers and biotechnology ventures. Global players bring established veterinary relationships, clinical research capability, and multi-country regulatory registrations, while regional and domestic companies compete on locally relevant strains, price positioning, and faster adaptation to national import and labelling requirements. Key success factors include veterinary endorsement, ingredient traceability and certification, and the ability to secure import registration under frameworks such as China's GACC and MARA systems. Leading companies are prioritising strain and postbiotic innovation, premium chew and functional-treat formats, and expansion into under-penetrated markets such as India and Southeast Asia, alongside selective partnerships and portfolio realignment, as illustrated by Unicharm's entry into India, H&H Group's expansion of its Zesty Paws brand into South Korea, and CJ CheilJedang's divestment of its livestock feed unit to sharpen focus on fermentation and microbiome science platforms.

Key Players

• Mars, Incorporated (United States)
• Novonesis (Denmark)
• DSM-Firmenich AG (Switzerland)
• Alltech, Inc. (United States)
• Kemin Industries, Inc. (United States)
• Lallemand Inc. (Canada)
• Vetoquinol S.A. (France)
• Unicharm Corporation (Japan)
• Nutramax Laboratories Veterinary Sciences, Inc. (United States)
• Tonisity International Limited (Ireland)
• Sirius Pet Biologics Pte. Ltd. (Singapore)
• Gambol Pet Group Co., Ltd. (China)
• PetPal Pet Nutrition Technology Co., Ltd. (China)
• Inaba Petfood Co., Ltd. (Japan)
• International Flavors & Fragrances Inc. (United States)

Recent Market Developments

• November 2025: Native Microbials and Zesty Paws, an H&H Group brand, announced a strategic partnership to develop a canine gut-health product line built on novel microbial species isolated from the gut microbiomes of healthy dogs, aimed at supporting canine digestive health.
• November 2025: H&H Group officially launched its Zesty Paws pet supplement brand in South Korea, extending its companion-animal wellness portfolio, including gut-health formulations, into a new Asia Pacific market.
• July 2026: Unicharm Corporation entered the Indian pet care market, launching its own brands through its local subsidiary, Unicharm India, citing India's pet population and long-term growth potential as key drivers of the move.
• September 2026: CJ Wellcare, a CJ CheilJedang affiliate, unveiled MACPlan, a gut-microbiome-focused wellness brand developed with microbiome specialist CJ Bioscience, at CPHI/Hi Korea 2026, reflecting how Korean fermentation and microbiome science built for human nutrition is increasingly informing companion-animal-adjacent product development.

Frequently Asked Questions